XBiotech Inc. (XBIT) Earnings History
Annual and quarterly earnings data from 2012 to 2024
Loading earnings history...
XBIT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
XBIT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | 83.8% | -860.1% | -820.4% |
| 2021 | 68.4% | -136.4% | -94.7% |
| 2020 | 21.5% | -41.5% | -25.5% |
Download Data
Export XBIT earnings history in CSV or JSON format
Free sign-in required to download data
XBiotech Inc. (XBIT) Earnings Overview
As of May 8, 2026, XBiotech Inc. (XBIT) reported trailing twelve-month net income of -$29M, reflecting -55.6% year-over-year growth. The company earned $-0.96 per diluted share over the past four quarters.
Looking at the long-term picture, XBIT's historical earnings data spans multiple years. The company achieved its highest annual net income of $669M in fiscal 2019.
XBiotech Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RCUS (-$369M net income, -142.9% margin), IMVT (-$464M net income), ARQT (-$2M net income, -4.3% margin), XBIT has comparable earnings metrics. Compare XBIT vs RCUS →
XBIT Earnings vs Peers
Earnings metrics vs comparable public companies
XBIT Historical Earnings Data (2012–2024)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$39M | -56.9% | -$42M | $-1.26 | - | - |
| 2023 | -$25M | +25.4% | -$38M | $-0.81 | - | - |
| 2022 | -$33M | -88.9% | -$34M | $-1.08 | -820.4% | -860.1% |
| 2021 | -$17M | -55.2% | -$25M | $-0.58 | -94.7% | -136.4% |
| 2020 | -$11M | -101.7% | -$18M | $-0.36 | -25.5% | -41.5% |
| 2019 | $669M | +3263.2% | -$31M | $14.44 | - | - |
| 2018 | -$21M | +36.2% | -$21M | $-0.59 | - | - |
| 2017 | -$33M | +37.2% | -$34M | $-0.95 | - | - |
| 2016 | -$53M | -40.8% | -$53M | $-1.63 | - | - |
| 2015 | -$37M | -72.5% | -$38M | $-1.22 | - | - |
See XBIT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XBIT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XBIT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXBIT — Frequently Asked Questions
Quick answers to the most common questions about buying XBIT stock.
Is XBIT growing earnings?
XBIT EPS fell to $-0.96, with earnings declining -55.6%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-29M.
What are XBIT's profit margins?
XBiotech Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are XBIT's earnings?
XBIT earnings data spans 2012-2024. The declining earnings trend is -55.6% YoY. Historical data enables comparison across business cycles.